About 39,300 cancer professionals from around the world met June 2-6 in Chicago for the American Society of Clinical Oncology Annual Meeting.
Researchers at the University of Michigan Comprehensive Cancer Center found an innovative approach to improve control of locally advanced lung cancer tumors while preserving more normal tissue. It involves a midtreatment PET-CT scan using the radioactive tracer fluorodeoxyglucose (FDG) and then individualizing escalated radiation to the target region the tracer identifies.
An investigation from the University of Michigan could eventually lead to new therapies that take aim at the most aggressive type of breast cancer -- triple-negative.
New research explains why this difficult-to-treat disease becomes resistant to chemotherapy, suggesting potential future treatment options.
In a dramatic shift since the publication of margin guidelines for breast cancer surgery, lumpectomy rates have substantially increased and more-aggressive surgical options have been used less often, a new study finds.
A new analysis finds that nearly three-quarters of 500 patients with advanced cancer could be referred to a potential targeted treatment based on the results of a comprehensive analysis of their tumor’s genetic landscape.